Standard Operating Procedure: Prothrombin Time (PT) and INR
1. Purpose and Scope
To measure the time required for plasma to clot after the addition of tissue factor (thromboplastin) and calcium, and to calculate the International Normalized Ratio (INR) for monitoring warfarin therapy.
2. Specimen Requirements
- Type: Platelet-poor plasma.
- Anticoagulant: 3.2% (0.109 M) Sodium Citrate (9:1 blood-to-anticoagulant ratio).
- Processing: Centrifuge at 1500-2000 × g for 15 mins within 2 hours of collection.
- Stability: 4 hours at room temperature.
- Rejection: Clotted, under-filled, or hemolyzed samples.
3. Safety and Precautions
- Standard PPE. Handle plasma as potentially infectious.
4. Equipment and Reagents
- Automated coagulation analyzer.
- PT reagent (thromboplastin containing tissue factor and calcium, or requiring added calcium).
- Citrate plasma controls (normal and abnormal).
5. Step-by-Step Procedure
- Bring reagents and controls to room temperature (or 37°C as per manufacturer).
- Run two levels of QC. Verify results are within range.
- Load patient plasma into the analyzer.
- The analyzer automatically dispenses plasma and pre-warmed PT reagent.
- The instrument detects clot formation (via optical or mechanical methods) and records the time in seconds.
- The analyzer automatically calculates the INR using the formula: INR = (Patient PT / Mean Normal PT)^ISI.
6. Quality Control
- Run QC with every new reagent lot, daily, or per lab policy.
- Verify the ISI (International Sensitivity Index) of the thromboplastin is correctly entered into the analyzer.
7. Reference Ranges
- The canonical adult reference intervals for PT and INR are shown in the Reference Ranges panel below.
Decision Limits
- INR (Therapeutic for most indications): 2.0-3.0
8. Reporting Results
- Report PT in seconds and INR.
- Flag critical values (e.g., INR > 4.5) for immediate clinical notification.